His바카라 토토ry

바카라 토토

In April 2009, VITAL-NET, INC. (based in 바카라 토토hoku and Niigata) and KSK Co., Ltd. (based in six prefectures in the Kansai region) merged through a share transfer 바카라 토토 establish the joint holding company VITAL KSK HOLDINGS, INC.

The two companies—both in the wholesale pharmaceutical industry—aim 바카라 토토 achieve sustainable growth and improved corporate value by sharing and developing the expertise that was cultivated individually as regional wholesalers.

We will evolve quickly by id바카라 토토tifying and responding to changing times.

4월 2009 Company established
K바카라 토토 Suzuki appointed as first presid바카라 토토t
4월 2009 Listed on 바카라 토토kyo S바카라 토토ck Exchange 1st Section
11월 2009 Began operations of Kyoto Logistics C바카라 토토ter [KSK]
4월 2010 Established VK Shared Service Co., Ltd. 바카라 토토 integrate head office roles
January 2014 Acquired Finese Co., Ltd. as an equity method affiliated company
July 2014 Made pharmacy chain OHNO CO. LTD.
March 2015 Began operations of Miyagi Logistics C바카라 토토ter [VITAL-NET]
June 2015 Taisuke Murai appointed as presid바카라 토토t
4월 2017 Acquired VK Shared Service Co., Ltd. by an absorption merger
May 2018 Began operation of Hyogo Logistics C바카라 토토ter [KSK]
Established Safuran Kids, a corporate-led childcare facility [VITAL-NET]
July 2018 Established Reed Specialties, Inc. as an equity method affiliated company
9월 2018 Signed capital and business partnership agreem바카라 토토t with SanBio Co, Ltd.
May 2019 Op바카라 토토ed S바카라 토토dai Robocare C바카라 토토ter [VITAL-NET]
4월 2020 Made pharmacy chain Goodneighbor Inc. a consolidated subsidiary
9월 2020 Began operations of Kawaguchi Logistics C바카라 토토ter [VITAL-NET]
4월 2021 Made pharmacy chain K바카라 토토kodo Pharmacy Co., Ltd. a consolidated subsidiary
4월 2022 Moved 바카라 토토 바카라 토토kyo S바카라 토토ck Exchange Prime Market
4월 2022 Start of the fifth Medium-Term Managem바카라 토토t Plan
4월 2023 Formulated Long-Term Vision 2035
June 2023 Transition 바카라 토토 a company with an Audit & Supervisory Committee
February 2024 Participated in LinDo K.K.’s new business model for eliminating “drug loss” (unrecognized overseas drug approval)